Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.
Rising to the Challenge of Biologic Drug Formulation
As biologics continue to push boundaries, the industry needs to take a holistic approach to formulation to ensure success.
Can the Price Ever be Right?
As drug pricing comes under the microscope internationally, it appears that collaboration with all stakeholders is key to tackling the issue.
Key Considerations in Stability Testing
Harmonization of best practices and regulatory requirements will enable developers to find the best stability testing approach.
Exploring Solubility Solutions
Drug solubility can benefit from approaching solubility issues early on in the drug lifecycle.
Packaging Peril: ‘No-Deal’ Brexit May Lead to Missed Deadline
As we approach the next instalment of Pharmapack Europe, a potentially perilous situation in relation to drug packaging has emerged for pharmaceutical companies should Brexit result in a ‘no deal’ scenario.
Changing Perceptions: An Understanding of Lyophilization Advancements
Technical advances in process understanding and control must be accompanied by a change in mindset.
A Week is a Long Time
Political instability is causing uncertainty in Europe and wreaking havoc with US regulatory timeframes.
Stimulating Discussion
A new initiative has been launched to help stimulate industry discussion on innovative tech for use across the drug supply chain.
Looking Beyond the Deadline
The EU FMD deadline is closing in, so now is the time to look beyond the short term.
Great Expectations
The new year has started with a bang in terms of mergers and acquisitions.
The Solubility Conundrum
Early adoption of the right approach to address solubility can deliver significant benefits.
Considering Protein and Peptide Delivery
New approaches seek to address formulation and delivery challenges for these complex molecules.
Regulatory Divergence: The Burden of Brexit?
As Brexit rapidly approaches, the lack of clarity around the regulatory balance between the regions could lead to a reduction in standards.
Pharmapack ‘Savoir Faire’
A brief preview of what to expect at pharma’s dedicated packaging and drug delivery event.
The Good, The Bad, and The Brexit
Taking stock on the ‘big-ticket’ news items, both good and bad, from the past 12 months.
Prioritizing Pragmatism in Face of a ‘No-Deal’ Brexit
During CPhI Worldwide in Madrid, Lynne Byers, executive director of NSF International detailed the facts about how Brexit can impact the pharmaceutical industry.
Fasten Your Seatbelts …
… Brexit may be a bumpy ride. Here, the new European editor of the PharmTech Group, Felicity Thomas, discusses Brexit and its implications for the pharma industry.